文献速递免疫规划

非洲和亚洲使用的活 attenuated 小反刍兽疫疫苗的热稳定制剂

A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia.
PubMed 文献 · Vaccine · 2017-05-29

研究旨在开发抗小反刍兽疫(PPR)的热稳定疫苗,将牛瘟冻干方法应用于 Nigeria 75/1 PPR 疫苗株,在 37°C 加速稳定性试验中测定保质期。使用乳白蛋白水解物和蔗糖(LS)稳定剂的三个批次在 37°C 下保质期分别为 177.6、105.0 和 148.9 天,56°C 下为 13.7 天,25°C 预计半衰期为 1.3 年,足以在无冷链条件下使用长达 30 天。

要点

  • LS 稳定剂 PPR 疫苗在 37°C 下保质期达 177.6、105.0 和 148.9 天(三个批次)。
  • 56°C 下保质期为 13.7 天,25°C 预计半衰期为 1.3 年。
  • 热稳定性足以支持无冷链使用长达 30 天,有助于全球 PPR 根除。

核心结论

  • 使用 LS 稳定剂和牛瘟冻干方法生产的 PPR 疫苗热稳定性最高,足以在无冷链条件下使用长达 30 天,将极大促进全球 PPR 根除中的疫苗接种。

研究设计与样本

  • 研究将牛瘟冻干方法应用于 attenuated Nigeria 75/1 PPR 疫苗株,在 37°C 加速稳定性试验中测定保质期。
  • 比较了乳白蛋白水解物和蔗糖(LS)稳定剂与基于海藻糖的稳定剂。
  • 比较了 Xerovac 干燥法与牛瘟冻干法生产的 PPR 疫苗。
  • LS 疫苗在 37、45 和 56°C 下进行加速稳定性试验,并构建 Arrhenius 图以估计未测试温度下的稳定性。

主要发现

  • 使用 LS 和牛瘟冻干方法生产的疫苗最稳定。
  • Xerovac 制剂在 37°C 下保质期为 22.2 天。
  • 三个 LS 疫苗批次在 37°C 下保质期分别为 177.6、105.0 和 148.9 天。
  • LS 疫苗在 56°C 下保质期为 13.7 天,25°C 下预计半衰期为 1.3 年。

关键数值与推荐

  • 保质期定义为在指定温度下西林瓶保留 25 剂呈现所需最低剂量的时间。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The research objective was to develop a thermostable vaccine against peste des petits ruminants (PPR), a morbilliviral disease of small ruminants targeted for eradication that is a major constraint on the livelihoods of the rural poor throughout much of Africa and Asia. Although existing PPR vaccines provide life-long immunity, they require continuous refrigeration. This limits their utility in developing countries. Methods for the lyophilization of a related morbillivirus, rinderpest (RP), resulted in vaccine that could be used in the field for up to 30days without refrigeration which was a major contribution to the global eradication of RP completed in 2011. The present research applied the rinderpest lyophilization method to the attenuated Nigeria 75/1 PPR vaccine strain, and measured thermostability in accelerated stability tests (AST) at 37°C. The shelf-life of the vaccine was determined as the time a vial retained the minimum dose required as a 25-dose presentation at the specified temperature. A lactalbumin hydrolysate and sucrose (LS) stabilizer was compared to stabilizers based on trehalose. PPR vaccine produced using the Xerovac drying method was compared to vaccine produced using the rinderpest lyophilization method in AST. LS vaccine was evaluated in AST at 37, 45 and 56°C and an Arrhenius plot was constructed for estimation of stability at temperatures not tested. Vaccines produced using LS and the rinderpest method of lyophilization were the most stable. The shelf-life of the Xerovac preparation was 22.2days at 37°C. The three LS vaccine batches had shelf-lives at 37°C of 177.6, 105.0 and 148.9days, respectively, at 37°C. At 56°C, the shelf-life was 13.7days. The projected half-life at 25°C was 1.3years. This is sufficient thermostability for use without a cold chain for up to 30days which will greatly facilitate the delivery of vaccination in the global eradication of PPR.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mariner JC, Gachanja J, Tindih SH, et al. A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia. Vaccine. 2017. PMID: 28566253. doi:10.1016/j.vaccine.2017.05.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。